Increased circulating platelet microparticles as a potential biomarker in asthma

    loading  Checking for direct PDF access through Ovid



Endothelial (EMPs) and platelet microparticles (PMPs) have been studied as biomarkers in several inflammatory diseases and as central players in intercellular communication.


In this cross-sectional study, we aimed to assess microparticle levels in asthma. Circulating microparticles and inflammatory and angiogenic markers were assessed by clinical and laboratorial evaluation, flow cytometry, and immunoassays, in a group of 20 asthmatic and 15 nonasthmatic subjects.


Circulating levels of PMPs (either CD31+/42b+ or CD31+/42b+/AnV+) were significantly increased in asthmatics (P = 0.021) even after adjustment for confounders. Apoptotic EMPs (CD31+/42b−−/AnV+) were significantly increased before (P = 0.005) but not after adjustments (P = 0.117).


We propose that PMPs may be putative asthma biomarkers, playing a role in asthma pathophysiology.

Related Topics

    loading  Loading Related Articles